EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Making Invisible Illnesses Visible: Recognizing and Responding to Infection-Associated Chronic Conditions

John K Iskander iD, Stephanie Haridopolos

Clinical Infectious Diseases · 23.07.2026 · 83 (1) · e58-e61

DOI: 10.1093/cid/ciag240 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 09.04.2026. Verfasst von John K Iskander und 1 weiteren Autor:innen. Beteiligte Einrichtung: Office of the US Surgeon General, Washington, DC, USA. Hauptthemen laut MEDLINE: Post-Acute COVID-19 Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: HHS, Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of post-COVID conditions (PCCs) has renewed attention to infection-associated chronic conditions and illnesses (IACCIs), including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Lyme disease–associated chronic symptoms. Millions of Americans are affected by these debilitating, misunderstood conditions, which share symptom profiles and pathophysiologic abnormalities. IACCIs have received insufficient clinical attention and research investment. We outline elements of a patient-centered approach to care, emphasizing validation of patients' experiences, multidisciplinary management, and symptom-focused treatment. Opportunities to strengthen clinical practice include a new Centers for Medicare and Medicaid Services (CMS) code for chronic condition management, extended visits, and creation of welcoming care environments. Advances in PCC and ME/CFS research provide a foundation for exploring shared mechanisms and developing targeted therapies. Improved surveillance, harmonized research, and inclusive trial designs are needed to define disease burden and accelerate therapeutic progress. Coordinated action by clinicians, researchers, and policymakers can help address longstanding gaps and improve outcomes for all individuals with IACCIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Post-Acute COVID-19 SyndromeHumansChronic DiseaseFatigue Syndrome, ChronicLyme DiseasePatient-Centered CareSARS-CoV-2United StatesFemaleAdult

Stichwörter der Autor:innen

Lyme diseaseME/CFSlong COVIDpost-COVID conditions

Autor:innen und Institutionen

  • Office of the US Surgeon General, Washington, DC, USA.
  • Public Health Service Commissioned Corps, Rockville, Maryland, USA.

ORCID-Profile: John K Iskander

Förderung

  • HHS
  • Department of Health and Human Services

Zitieren

APA

Iskander, J. K., & Haridopolos, S. (2026). Making Invisible Illnesses Visible: Recognizing and Responding to Infection-Associated Chronic Conditions. Clinical Infectious Diseases, 83(1), e58-e61. https://doi.org/10.1093/cid/ciag240

Vancouver

Iskander JK, Haridopolos S. Making Invisible Illnesses Visible: Recognizing and Responding to Infection-Associated Chronic Conditions. Clinical Infectious Diseases. 2026;83(1):e58-e61. doi:10.1093/cid/ciag240

BibTeX
@article{Iskander2026,
  author = {Iskander, John K and Haridopolos, Stephanie},
  title = {Making Invisible Illnesses Visible: Recognizing and Responding to Infection-Associated Chronic Conditions},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {83},
  number = {1},
  pages = {e58--e61},
  doi = {10.1093/cid/ciag240}
}
Kostenlos starten →